For further information on all the BioMed Central Impact Factor journals read our latest blog post.
Springer Science+Business Media, BioMed Central's parent company recently announced the significant expansion of its open access publishing activity with the launch of SpringerOpen, a new series of open access journals that will span all STM disciplines.
The SpringerOpen journals will complement existing Springer titles and include the following:
Health Economics Review
Journal of Remanufacturing
Environmental Sciences Europe
Security and Intelligence Informatics
Psychology and Well-Being Research
BioMed Central's open access publishing expertise and technology is helping Springer to launch this new series of titles. All SpringerOpen journals will be included within our pioneering Membership Program.
BioMed Central is delighted to announce the launch of its Shared Support Membership package. This pioneering new model offers a manageable cost-effective alternative for both the institution and author.
Shared Support Membership works by allowing the institution and author to split the article processing charge equally. Similar to our Prepay package, Shared Support Members are entitled to concessions. The higher the amount paid in advance the greater the loyalty discount given on each APC.
For more information about our Membership Program and the different packages we have, simply visit our Membership page or contact your Sales Representative who would be delighted to talk through your options with you.
Automated Article Deposit - available at no extra charge to all Members and Open Repository customers
Our new Automated Article Deposit service enables the simple transfer of an institution's complete published article content from BioMed Central's journals into the institution's repository. Based on the SWORD protocol (Simple Web-service Offering Repository Deposit) any open access article published in a BioMed Central journal will be automatically deposited in its official final published form into the author's institutional repository.
To celebrate the launch of Alzheimer's Research & Therapy and Stem Cell Research & Therapy all subscription content including reviews, reports, commentaries and editorials is FREE until January 2011. Please do spread the word to your researchers.
TAKE OUT A TRIAL BEFORE YOU BUY
Why not take out a complimentary 30 day free trial to the Journal Collection? We will provide you with promotional material to advertise the trial around your institution and full usage statistics on completion to help you make an informed decision on the success of your trial.
Open Repository has continued to show its support for the repository community with a major presence at the Open Repositories 2010 Conference. We are also a key sponsor of SPARC 2010, taking place in Baltimore this November.
Open Repository is pleased to announce that our customers have also been promoting their repositories. ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility) and Wilfrid Laurier University, both recently presented posters at conferences explaining their reasons for developing a repository and the process they went through.
Details of where Open Repository will be exhibiting can be found on our website. If you are interested in arranging a meeting or would like any further information about Open Repository, please get in touch.
If you would like to receive more regular updates about Open Repository then why not sign up to receive the Open Repository newsletter? The next issue is available soon.
BioMed Central's 10th anniversary – Genome Biology moves to a new website platform
This year, BioMed Central is delighted to be celebrating its 10th anniversary, representing a decade of successful open access publishing. With over 200 journals, 15,000 published articles and over 1.2 million registrants, BioMed Central is one of the world's leading open access publishers.
As part of this celebration, we have been launching our journals on to a new website platform. Genome Medicine made the transition in January, and now BioMed Central's highest ranking journal, Genome Biology, has become the latest title to move across.
The new site has been designed to provide a new improved look for the journal as well as
enhance user experience. Please do encourage your researchers to visit the site and experience the new features for themselves.
You can also take out a free one month trial so that everyone at your institution can browse the site to access all there is to offer. During the trial, they can have immediate access to all subscription-only content through IP recognition and you can receive a report with full usage statistics after the trial to help you make an informed decision.
Attending a conference in 2011? Let us know where you will be.
Open Repository Sales Representative news
BioMed Central is happy to announce that your local Sales Representative will now be working on Open Repository. This means that you now have one contact who can provide you with an even greater insight into BioMed Central's product range. For more details contact your Sales Representative.
Welcoming Calum Land to the team
Calum Land has joined us as Head of Sales while Marianne Haska is on maternity leave. Calum has worked in the publishing industry for over ten years with successful roles at Current Drugs Ltd and Thomson Reuters. Since 2006 he has been running a company he co-owned that designed and built digital information solutions for clients ranging from the British Standards Institution and Science Navigation Group to HRH The Prince of Wales. Originally from The Lake District, Calum now lives in North London with his wife, one-year-old son and two cats.
On the road with North American Sales Manager Bob Schatz
Our North America Sales Manager, Bob Schatz, has been busy attending library shows around the US. Here he gives a rundown of his recent travels:
"Late May to late June is a busy time in North America. In quick succession I attended conferences for the Medical Library Association, Canadian Library Association, Special Libraries Association, and American Library Association, which took me to Washington DC, Edmonton, New Orleans, and back to Washington.
In some cases, the number of librarians attending was down, evidence of tighter travel budgets in this tough economy. Budget concerns in general were much the topic of conversation with those who did attend. Perhaps this is why there was such high
interest in our open access activities, especially at ALA where Springer, our parent company, announced the launch of its own list of open access journals under the SpringerOpen name.
I've always been impressed with how well librarians face challenges and look for forward-thinking solutions, even in the most trying conditions. It would appear that more than a few librarians believe our open access publishing represents an important part of those solutions. Interest in our publications and our Memberships has never been higher: proof that challenging times can still be exciting times."